🧴 Bemotrizinol is the first new active sunscreen ingredient permitted in the U.S. since 1999. 🥇 It is also the first chemical-based sunscreen filter to receive GRASE status from the FDA. Perspectives from @AdeAdamson and @rossidermmd 👇 vist.ly/57d7c

💥 The first new active sunscreen ingredient in over 2 decades has hit the U.S. market. ☀️ The @US_FDA has added bemotrizinol, a sunscreen filter widely used in Europe, to the list of permitted active sunscreen ingredients. vist.ly/575vr @GoHealio @AdeAdamson

🧴 There are three key features to look for in a sunscreen formulation: 1⃣ broad-spectrum protection 2⃣ SPF of at least 30 3⃣ water resistance if swimming Watch the latest @GoHealio Beneath the Surface episode with @AdeAdamson to learn more! healio.com/news/dermatology/… @HemOncToday

Do Black people need daily sunscreen? The answer is more nuanced than many people think. BIN’s Misty Jordan chats with board-certified dermatologist Dr. @AdeAdamson as he breaks down the facts and clears up common misconceptions. Tune in! 📻: iheart.com/podcast/1248-blac…

🧴 Knowing what to look for in a sunscreen is important when choosing a sun protection product. 📹 In the latest Beneath the Surface episode, @DrJoelGelfand and @AdeAdamson discuss how to read a sunscreen label. vist.ly/5677i @GoHealio @HemOncToday

Essential read on the deeply FLAWED design of the taxpayer-funded GRAIL Galleri-Medicare study of cancer screening. Its called the "REACH" study but it is more of a GRAB. A veritable shakedown of the American taxpayer.

This person has published 71 papers in 143 days so far in 2026. That is, 2 days per paper (source: Google Scholar). It's truly amazing. To see someone proud of this.

🩴Summer is coming! Before you start spending more time in the sun, make sure you're applying sunscreen correctly to protect your skin. @DrJoelGelfand talks with @AdeAdamson about: 🧴How much sunscreen to use 🧴How soon to apply and reapply 🧴And more! healio.com/news/dermatology/…

Running with Scissors: AI and the Race for the Future ethicsunwrapped.utexas.edu/v… via @@ethicsunwrapped grateful to be interviewed for this documentary!

NEJM retracts case study for AI-manipulated imagery. retractionwatch.com/2026/05/…

The problem with some of our best ideas in infectious diseases? They’re also the most frustrating. Six love-hates in ID (and bonus @IDSAInfo podcast). Link in reply ...

Its wild how much attention this has received. This technology already exists (has for many years) and in the only RCT looking at effectiveness in melanoma screening it did not improve outcomes in high risk people: jamanetwork.com/journals/jam… Cool looking robot though...

🧵1/ Our new study on AI and physician reasoning just came out in @ScienceMagazine. As co-senior author, I'm excited about our findings, and I do think AI will reshape medicine. But after seeing some of the discussions, I'm also worried about how our findings may be misinterpreted.

Deployment of AI tools in healthcare is getting ahead of the evidence. Here is a validation study of a *commercially available* radiology tool designed to detect misplaced nasogastric tubes, which can lead to disastrous outcomes. It missed 13% of them! ai.nejm.org/doi/full/10.1056…

Ugly. I’m very skeptical many care but regardless hospitals & blood banks must stand totally firm in refusing to entertain requests for “unvaccinated” blood or non-evidence-based “directed” donation. This is madness that harkens back to racial segregation of blood supply.

There is something deficient here and it ain't vit D...

U.S. government has lost more than 10,000 STEM Ph.D.s since Trump took office science.org/content/article/…

📈 The rising number of dermatology-specific advanced practice clinicians is associated with a growing share of dermatology drug spending, specifically in specialty medications. 🗣️ @AdeAdamson discussed with @GoHealio what this means. @JAMADerm vist.ly/4nnw8

If we talk about mortality, even with the increasing mortality rate for colorectal cancer, this cannot realistically be "felt" in clinic, the rise is impossible to be clinically "detectable" by a single physician. (see screenshot: colorectal : from 2.7 to 3.1/100 000/y over 30 years) When it comes to incidence and diagnoses, things are more complex. That's why we need works like the one published in @JAMAInternalMed, based on facts and numbers. @AdeAdamson and colleagues provided a balanced analysis which is often lacking in that space. Actually, I think their work is highly needed to be able to identify and focus on cancers where an actual increase in mortality is seen. See the nice discussion with @AdeAdamson here : theoncologyshot.com/p/are-fe…

This is one of the hardest concepts for people to understand, from patients to doctors to scientists to biotech industry